Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Site News
Market: Market:

Tracon Pharma (TCON)

Tracon Pharma (TCON)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
TRACON Pharmaceuticals to Present at the Jefferies Healthcare Conference Globe Newswire - Thu Jun 2, 7:05AM CDT

SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development...

TCON : 1.98 (-1.00%)
TRACON Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference Globe Newswire - Mon May 16, 7:05AM CDT

SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development...

TCON : 1.98 (-1.00%)
TRACON Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update Globe Newswire - Wed May 11, 3:02PM CDT

SAN DIEGO, May 11, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the...

TCON : 1.98 (-1.00%)
TRACON to Report First Quarter 2022 Financial Results and Corporate Update on May 11, 2022 Globe Newswire - Wed May 4, 7:05AM CDT

SAN DIEGO, May 04, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development...

TCON : 1.98 (-1.00%)
TRACON Pharmaceuticals Announces Amended ENVASARC Protocol Approved and Open at all 30 Clinical Sites in the U.S. and U.K. Globe Newswire - Tue Apr 19, 7:05AM CDT

Expects to Report Results of Independent Data Monitoring Committee (IDMC) Mandated Interim Safety Reviews and Interim Efficacy Review in the Second Half of...

TCON : 1.98 (-1.00%)
Author
Recession Fears are Creating a Golden Opportunity for Biotech Stocks InvestorPlace - Fri Apr 8, 4:02PM CDT

It's worth taking the effort to learn how to invest in biotechs

LGVN : 5.94 (+0.17%)
AZN : 65.95 (-0.18%)
TCON : 1.98 (-1.00%)
RIOT : 4.24 (+1.19%)
BIIB : 210.63 (+3.28%)
TRACON Pharmaceuticals to Present at the Maxim Group 2022 Virtual Growth Conference Globe Newswire - Wed Mar 23, 7:05AM CDT

SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...

TCON : 1.98 (-1.00%)
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update Globe Newswire - Tue Mar 15, 3:02PM CDT

Announced FDA Approval of Amended ENVASARC Protocol, ENVASARC Interim Efficacy Data on Track for 2H22Initiating combination trial of proprietary CTLA-4...

TCON : 1.98 (-1.00%)
TRACON Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference Globe Newswire - Fri Mar 11, 7:05AM CST

SAN DIEGO, March 11, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...

TCON : 1.98 (-1.00%)
TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASARC Protocol Globe Newswire - Thu Mar 10, 7:05AM CST

Patient dosing underway, interim efficacy data on track for second half 2022...

TCON : 1.98 (-1.00%)

Barchart Exclusives

2 BDC Stocks Yield Over 10% With Excellent Covered Call Plays Barchart - Fri Jul 1, 12:39PM CDT
These 2 business development companies (BDCs) yield over 10%, even before some extra quarterly dividends they have been issuing. In addition, they off excellent covered call opportunities for investors. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' : 'America/Chicago' ]] CDT
Reserve Your Spot